跳至主要内容
临床试验/NCT04740541
NCT04740541招募中不适用

Determination of Threonine Requirement in Adult Males With Crohn's Disease Using the Indicator Amino Acid Oxidation (IAAO) Methodology

The Hospital for Sick Children2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2024年2月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
10
试验地点
2
主要终点
Requirement of Threonine in Adult Males with Crohn's Disease

研究概览

简要总结

The goal of the current study is to measure the requirement for threonine in patients with CD using the IAAO method and compare the requirement to previously determined threonine requirement estimated in young adults using the IAAO technique. It is hypothesize that the requirement for threonine in patients with CD will be higher than the threonine requirement previously determined in young adults using the IAAO method. Up to 10 clinically stable patients with CD will be recruited from the IBD Clinic at Mt. Sinai Hospital, Toronto, and subsequently followed up at the Clinical Research Center (CRC), The Hospital for Sick Children (SickKids), Toronto, Canada. Before the study begins, the participants will be required to visit the CRC (Room 5500 Hill Wing, The Hospital for Sick Children) for a pre-study assessment of their height, weight, fat mass, fat free mass, resting metabolic rate and medical history. These assessments will take about 3 hours to complete. They will need to have been fasted for 10 hours prior to the pre-study assessment. The pre-study assessment is needed to calculate their dietary requirements for the study, and to assess health status. After signing the consent form, the subjects will complete the screening procedures (height, weight, fasting blood sample and medical history questionnaire, BIA, Skinfold and calorimetry).

Each study will consist of a 2-day adaptation period to a prescribed diet in accordance with the energy requirement of the subject and 1-study day. The diet will provide an adequate amount of protein, of 1 g protein/kg/d. The 2-day adaptation period is to allow the body to adapt to an adequate amount of protein as it has been shown that protein kinetics is altered without it.

Dietary intakes during this time will be provided in the form of lactose-free milk shakes (Scandishake) with added carbohydrate (SolCarb) and protein (beneprotein) to meet the subjects' requirement.

Following the 2 days of adaptation is the study day where threonine intake will be randomly assigned and phenylalanine (Phe) kinetics will be measured with the use of isotopically labelled Phe. On this day, VCO2 will be measured by calorimetry immediately after the 5th meal for a period of 20 minutes.

On the study day (3rd day of each 3-day period), the diet will be provided as 8 hourly isocaloric, isonitrogenous meals made up of a flavored liquid formula and protein free cookies developed for use in amino acid kinetic studies. Each meal will represent 1/12th of the subject's total daily requirements. The nitrogen (protein) content of the diet will be provided in the form of a crystalline amino acid mixture based on the amino acid composition of egg protein.

  • A daily multivitamin supplement will be provided during the study period.
  • No other food or beverages will be consumed on the adaptation days except water, 1 cup clear tea, or 1 cup clear coffee.
  • During the 8-hr study day, no other food or drink will be consumed except water.
  • Urine and breath samples will be collected at baseline and at isotopic steady state.
  • Breath samples will be collected simultaneously with urine samples.
  • Five baseline breath samples will be collected 60, 45, 30, 15 min, and just before the tracer protocol begins.
  • Three baseline urine samples will be collected 60, 30 min, and just before the tracer protocol begins.
  • Four plateau breath samples will be collected every 15 minutes 2.5 h after the tracer protocol begins.
  • Three plateau breath samples will be collected every 30 minutes 2.5 h after the tracer protocol begin
  • Breath samples will be collected with subjects breathing into an Exetainers plastic tube and samples will be stored in pre-evacuated glass tubes at room temperature until analysis.
  • Urine samples will be collected in Eppendorf tubes and stored at - 20 º C until analyzed for 1-13C phenylalanine enrichment.
  • The rate of CO2 production (VCO2) will be measured on each testing day using a ventilated hood indirect calorimeter at meal 5 to quantify 13CO2 excretion in breath.

Subjects can choose to withdraw from the study at any time and for any reason, based on his/her individual judgment. In particular, if a subject is unable to tolerate the diet, whether it is regards to taste, loose stools or constipated stools, he/she has the right to withdraw at any time during the study.

详细描述

BACKGROUND The current Dietary Reference Intake (DRI) recommendations for essential amino acid requirements are based on recommendations for young healthy adults and have not been directly determined in patients with Crohn's disease. Protein and amino acids are key components of our diet. Having defined the requirement of the essential amino acid, Threonine in healthy adults using the IAAO, the investigators are now in an ideal position to define the needs in vulnerable populations, such as patients with chronic inflammatory conditions, such as Crohn's disease (CD).

Studies in animals suggest an increase in the threonine requirement in Crohn's and colitis models. If this is also true in humans, knowledge of the threonine requirement in patients with IBD could provide valuable information for improvement in medical nutritional management of this patient population. Improved medical nutrition therapy could likely shorten recovery time and/or increase the period of remission in patients with IBD.

Method:

Indicator Amino Acid Oxidation

Hypothesis:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 49 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Male 18 - 49 years of age
  • Having obtained his (or his legal representative's) written informed consent
  • Evidence of ileal and or colon inflammatory involvement and clinically stable disease state and HBI ≤ 8
  • Evidence of some active disease based on history of elevated CRP or parameters of active mucosal
  • No evidence of intestinal strictures that may affect the subjects' ability to consume a normal diet
  • Have maintained a stable weight for at least 3 months and not on enteral feed via tube
  • Willingness to participate in the study and completed the screening procedures (height, weight, fasting blood sample and medical history questionnaire) and willingness to consume the diet provided

排除标准

  • Uncontrolled inflammation which will likely require surgery or escalation of therapy in the next 4 weeks
  • Concomitant treatment: corticosteroid > 20 mg/day
  • Subjects without any evidence of inflammatory activity
  • On medications known to affect protein and amino acid metabolism (steroids)
  • Recent significant weight loss
  • Individual on weight reducing diets
  • Inability to tolerate the diet
  • Subjects who cannot be expected to comply with the study procedures
  • Significant coffee consumption of more than 2 cups/day
  • Significant alcohol consumption of more than one drink/day

研究组 & 干预措施

Threonine Requirement in CD Patients

Experimental

Males aged 18 - 49 with stable Crohn's disease will be seen for pre-study They will be studied up to 5 times for different levels of threonine intakes.

干预措施: Dietary Intakes (Reference protein drinks (Scandishake, Solcarb, Beneprotein) and cookies) (Other)

结局指标

主要结局

Requirement of Threonine in Adult Males with Crohn's Disease

时间窗: 1 - 6 months

Apply IAAO method to determine the DRI for Threonine in CD patients

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Glenda Courtney-Martin

Project Investigator

The Hospital for Sick Children

研究点 (2)

Loading locations...

相似试验

Threonine Requirement in Adult Males With Crohn's... | 临床试验